Prosecution Insights
Last updated: April 19, 2026
Application No. 17/927,447

METHOD FOR PRODUCING CATALYST FOR POLYMERIZATION OF OLEFIN, CATALYST FOR POLYMERIZATION OF OLEFIN, AND METHOD FOR PRODUCING POLYMER OF OLEFIN

Final Rejection §102§DP
Filed
Nov 23, 2022
Examiner
LEE, RIP A
Art Unit
1762
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Toho Titanium Co., Ltd.
OA Round
2 (Final)
83%
Grant Probability
Favorable
3-4
OA Rounds
2y 8m
To Grant
78%
With Interview

Examiner Intelligence

Grants 83% — above average
83%
Career Allow Rate
1119 granted / 1345 resolved
+18.2% vs TC avg
Minimal -5% lift
Without
With
+-4.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
36 currently pending
Career history
1381
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
31.8%
-8.2% vs TC avg
§102
25.5%
-14.5% vs TC avg
§112
24.4%
-15.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1345 resolved cases

Office Action

§102 §DP
DETAILED ACTION This office action follows a response filed on December 23, 2025. Claims 1 and 4-8 were amended, and new claims 9 and 10 were added. Claims 1-10 are pending. Claim Objections Claim 9 is objected to because of the following informalities: In line 1, please replace “The catalysts” with “The catalyst”. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-7, 9, and 10 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1, 2, 4, 6, 7, 9, and 10 of U.S. Patent No. 12,428,503. Although the claims at issue are not identical, they are not patentably distinct from each other. Patent claims are drawn to substantially the same method for producing a catalyst for polymerization of an olefin comprising contacting a solid catalyst component (A) comprising magnesium, titanium, halogen, and an internal electron donating compound and an organoaluminum compound (B) with each other, wherein at least one selected from the solid catalyst component (A) or the organoaluminum compound (B) is previously subjected to contact treatment with a hydrocarbon compound having one or more vinyl groups. While patent claims do not recite the identity of an internal electron donating compound, one gleans from the disclosure that the internal electron donating compound is 2-ethoxyethyl-1-ethyl carbonate (EEECA). Applicant’s attention is drawn to MPEP § 804 where it is disclosed that “the specification can always be used as a dictionary to learn the meaning of a term in a patent claim.” In re Boylan, 392 F. 2d 1017, 157 USPQ 370 (CCPA 1986). Further, those portions of the specification which provide support for the patent claims may also be examined and considered when addressing the issue of whether a claim in an application defines an obvious variation of an invention claimed in the patent. In re Vogel, 422 F.2d 438, 164 USPQ 619,622 (CCPA 1970). Response to Arguments The rejection of claim 4 under 35 U.S.C. 112(b), set forth in paragraph 8 of the previous office action dated August 25, 2025, has been withdrawn in view of claim amendment. The rejections of claims under 35 U.S.C. 102(a)(1) as being anticipated by Kataoka et al. (JP 7-173213), Kataoka et al. (JP 10-36430), Kamimura et al. (US 9,353,198), and Kamimura et al. (JP 2015-193787), set forth in paragraphs 10-13 of the previous office action, have been overcome by amendment. Allowable Subject Matter Subject of claims is patentably distinct over the references listed in the accompanying PTO-892. Hosaka et al. (US 9,587,050, US 9,593,188, US 9670,294), Umebayashi et al. (US 11,236,189), and Sugano et al. (US 10,457,755), and Konno et al. (US 12,331,138) teach use of 2-ethoxyethyl ethyl carbonate or 2-ethoxyethyl methyl carbonate as an internal election donor for preparation of a solid catalyst component. Coalter et al. (US 8,263,520, US 8,633,126), Sainani et al. (US 10,160,816), and Zhang et al. (CN 107344973, C 107344977, CN 107344979, CN 1034497980) teaches use of a decarbonate compound as internal electron donor for preparation of a solid catalyst component. All references teach contacting the solid catalyst component with an organoaluminum compound to make a polymerization catalyst. None of cited references teaches claimed process wherein at least one selected from w solid catalyst component or an organoaluminum compound is previously subjected to contact treatment with a hydrocarbon compound having one or more vinyl groups. For purposes of filling out PTO-892, status of claim 8 is listed as “objected to”. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Rip A. Lee whose telephone number is (571)272-1104. The examiner can be reached on Monday through Friday from 9:00 AM - 5:00 PM. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Jones, can be reached at (571)270-7733. The fax phone number for the organization where this application or proceeding is assigned is (571)273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /RIP A LEE/Primary Examiner, Art Unit 1762 February 25, 2026
Read full office action

Prosecution Timeline

Nov 23, 2022
Application Filed
Aug 21, 2025
Non-Final Rejection — §102, §DP
Dec 23, 2025
Response Filed
Feb 25, 2026
Final Rejection — §102, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600807
POLYPROPYLENE FILM WITH IMPROVED SLIP PERFORMANCE
2y 5m to grant Granted Apr 14, 2026
Patent 12600805
FLUORINE-CONTAINING ALKYL AMMONIUM BORATE COMPOUND AND METHOD FOR PRODUCING SAME
2y 5m to grant Granted Apr 14, 2026
Patent 12595322
GAS-PHASE BIPHENYLPHENOL POLYMERIZATION CATALYSTS
2y 5m to grant Granted Apr 07, 2026
Patent 12594538
CONTINUOUS PROCESSOR UTILIZING QUANTUM FIELD MICRO-VARIABLE PARTICLE INTERACTION
2y 5m to grant Granted Apr 07, 2026
Patent 12590245
LONG-PERSISTENT LUMINESCENCE EMITTER AND LONG-PERSISTENT LUMINESCENT DEVICE
2y 5m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
83%
Grant Probability
78%
With Interview (-4.7%)
2y 8m
Median Time to Grant
Moderate
PTA Risk
Based on 1345 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month